Claims
- 1. A pharmaceutical composition for inhibiting matrix metalloproteinases containing a compound of the general formula (I), a prodrug, a pharmaceutically acceptable salt, or a solvate thereof as an active ingredient:
- 2. A compound of the following formula:
- 3. A pharmaceutical composition which contains as an active ingredient a compound as described in claim 1.
- 4. A pharmaceutical composition which contains as an active ingredient a compound as described in claim 2.
- 5. A method for inhibiting matrix metalloproteinases by administering to a mammal a therapeutically effective amount of a compound as described in claim 1.
- 6. A method for inhibiting matrix metalloproteinases by administering to a mammal a therapeutically effective amount of a compound as described in claim 2.
- 7. The method according to claim 5 wherein the mammal is a human.
- 8. The method according to claim 6 wherein the mammal is a human.
- 9. A method for treating lung cancer which comprises administering to a mammal a therapeutically effective amount of the compound of claim 1.
- 10. A method of treating lung cancer by administering to a mammal a therapeutically effective amount of the compound as described in claim 2.
Priority Claims (1)
Number |
Date |
Country |
Kind |
2000-120234 |
Apr 2000 |
JP |
|
Parent Case Info
[0001] This is a divisional of Ser. No. 10/257,917, filed Oct. 18, 2002 which is a 371 of PCT/JP01/03214, filed Apr. 16, 2001.
Divisions (1)
|
Number |
Date |
Country |
Parent |
10257917 |
Oct 2002 |
US |
Child |
10730946 |
Dec 2003 |
US |